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Article history:
Received 19 May 2014
Received in revised form
9 July 2014
Accepted 9 July 2014
Available online 15 July 2014
Keywords:
CABG
Composite Y-grafts
99mTc-sestamibi SPECT
Multi-slice computed tomography* Corresponding author. Via S. Domenico 62, 80127
E-mail address: vitomannacio2@libero.it (V. Mann
http://dx.doi.org/10.1016/j.ijsu.2014.07.008
1743-9191/© 2014 Surgical Associates Ltd. Publisheda b s t r a c t
Background. This retrospective cohort study investigated the functional and haemodynamic mid-term
results over 3-years follow up of the left internal mammary artery (LIMA) conduit in composite Y-graft
conﬁguration with radial artery (RA) in a population of patients who underwent off-pump coronary
artery bypass grafting (CABG). Methods. 148 patients who underwent off-pump CABG with composite
Y-graft, were evaluated over 3-year follow up. Two-day dipyridamole induced maximal hyperaemia/
rest 99mTc-sestamibi was scheduled preoperatively and 36 months after surgery for functional
evaluation. Morphological evaluation was performed by 64 slice multidetector computed tomography
(CT) 36 months after surgery. Results. Clinical adverse events were rare within 3 years follow up.
Minimal to severe scintigraphic evidence of stress induced ischaemia occurred in 24 patients. Left
ventricular (LV) hypertrophy (HR 3.1; 95% CI, 1.5e9.3; p ¼ 0.01) and poor coronary run off (HR 4.1; 95%
CI, 2.1e10.8; p ¼ 0.005) were signiﬁcant multivariate predictors of reversible stress induced ischaemia.
64 slice multidetector CT showed that the main stem of Y composite grafts was patent in all patients,
while distal LIMA or RA was stenosed or occluded in 9 patients. Conclusion. Composite Y-graft was
adequate to meet the ﬂow requirements of target coronary artery either at rest or during maximal
hyperaemia. The use of Y-graft should be carefully evaluated in patients with LV hypertrophy and/or
poor coronary run-off.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The composite grafts in Y or T conﬁguration have gained wide
popularity because they allow sufﬁcient length and maximal arte-
rial graft economy while avoiding unnecessary aortic manipulation
in patients at risk of neurologic injury for diffuse circumferential
atherosclerotic involvement of the ascending aorta [1e5]. InNaples, Italy.
acio).
by Elsevier Ltd. All rights reservedaddition to the left or the right internal mammary artery (LIMA,
RIMA), the radial artery (RA) has emerged as the main secondary
conduit option for composite Y or T conﬁguration with several
studies reporting its superiority compared to saphenous graft or
other alternative conduits if used under the most promising con-
ditions [6e9]. However, composite grafts could have an inherent
limitationwhere the newly constructed coronary ﬂow is dependent
on a single conduit. Although literature is not uniform, several
studies demonstrated that composite Y-grafts are able to supply
sufﬁcient ﬂow to distal branches at rest and during maximal
hyperaemia [4,5,10e13]..
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morphological mid-term results of the LIMA conduit in composite
Y-graft conﬁguration with the RA in a population of patients who
underwent off-pump coronary artery bypass grafting (CABG). 64-
slice multidetector computed tomography (CT) and 2-day dipyr-
idamole induced maximal hyperaemia/rest 99mTc-sestamibi
myocardial perfusion single-photon emission computed tomogra-
phy (SPECT) were employed for functional and morphological
assessment 36 months after surgery.2. Material and methods
Study design and patient population were compliant with the
STROBE criteria (Strengthening the reporting of observational
studies in epidemiology) [14].
From May 2005 to June 2010, of a total of 900 patients under-
went primary off-pump CABG, 148 patients who received LIMA/RA
conduits as a composite Y-grafts were retrospectively collected and
analysed. Exclusion criteria were on-pump CABG, age greater than
80 years, low ventricular function (ejection fraction <30%), addi-
tional cardiac or surgical procedures, severe systemic comorbidities
(dialysis, hepatic failure) and contraindication to pharmacologic
(dipyridamole) stress testing or angio computed tomography.
Anatomic selection criteria for off-pump operations were vessel
size (>1.2 mm) and freedom from diffuse coronary calciﬁcations
whereas clinical selection criteria included the absence of me-
chanical and electrical instability in the operating theatre. Surgical
indications were assessed as a greater than or equal to 70% diam-
eter stenosis. Coronary stenoses were evaluated by the Quantitative
Coronary Angiography Data System (Centricity Carddas Xi2, GE
Healthcare, Burlington, VT). The number of coronary lesions was
deﬁned as the total number of stenoses greater than or equal to
70%. Coronary blood ﬂow was assessed by means of the throm-
bolysis in myocardial infarction (TIMI) frame-counting method
with a frame counter on the cineviewer. Corrected TIMI frame
count was derived for the longer left anterior descending (LAD)
[15]. Demographics and clinical features of the population of study
are described in Table 1.
The study protocol was approved by the ethic committee of the
University of Naples Federico II. All patients preliminarily granted
permission for the use of their medical records for research pur-
poses, hence, individual patient consent was waived for this study.
However, individual consent was obtained for each instrumental
screening performed at follow-up.Table 1
Main demographic and clinical characteristics.
Characteristics 148 patients
Age 67 ± 14
Gender (male) 95(64.1%)
BMI kg/m2 29.2 ± 7.8
History of MI 58(39.1%)
Diabetes 72(48.6%)
Hypertension 55(37.1%)
Dyslipidemia 64(43.2%)
HDL mg/dl 78 ± 15
Chronic obstructive lung disease 62(41.8%)
Creatinine mg/dl 0.8 ± 0.6
Left main stem disease 23(15.6%)
Left ventricular hypertrophy (ILVM > 125 mg/m2) 38(25.6%)
Preoperative LVEF < 40% 31(21.2%)
Left anterior descending CTFC 29.2 ± 7.3
Peripheral vascular disease 13(8.7)
Values are mean ± SD or numbers. BMI, Bodymass index; CTFC, corrected TMI frame
count; HDL, high density lipoprotein; ILVM, indexed left ventricular mass; LVEF, left
ventricular ejection fraction; MI, myocardial infarction.2.1. Surgical procedure
The LIMA was harvested as a skeletonized graft as previously
described [5,16]. Diluted papaverine (100 mg/100 mL Ringer's solu-
tion) was sprayed on the artery thenwrapped in papaverine-soaked
gauze. Intraluminal papaverine was not routinely used to avoid
damages bymanipulations and acidic pH.When required by the low
ﬂow, it was neutralized by diluting in heparinized blood. The RAwas
harvested from the nondominant arm as a pedicled conduit preser-
ving the satellite veins and surrounding tissue by means of an
UltracisionHarmonic scalpel (EthiconEndo-Surgery, Cincinnati,OH),
distended to a moderate pressure (about 180 mm Hg) with blood
diluted papaverine (100 mg/100 mL blood), and placed in a warm
solution. The LIMA was always grafted to the LAD while RA was
anastomosed to the left coronary artery (diagonal or circumﬂex).
The RA in the composite Y-graft conﬁgurationwith the LIMAwas
used as an alternative to the RIMA when there were contraindica-
tions to bilateral IMAs use. As general rule, we did not harvested
both IMAs in patients with body mass index >30, diabetes mellitus,
chronic obstructive lung disease (associated with severe emphy-
sema and/or long-standing steroid treatment) or in patients with
fragile sternum, as from osteoporosis. Proximal critical stenosis
(greater than or equal to 85%e90%) and size of at least 1.5 mm and
freedom from calciﬁcation or extensive atherosclerotic disease (or
both) of the target vessel at preoperative cineangiography were
mandatory indications for RA anastomosis [17,18]. Wherever
required, only saphenous vein grafts were used for additional right
coronary artery revascularization. A transit-time ﬂow meter (HT
323-CS; Transonic Systems Inc, Ithaca, NY) was used for graft ﬂow
measurements as previously described [5]. Each limb of the Y-graft
was evaluated after the Y-anastomosis was completed and after the
all conduits were anatomized distally on the target coronary ar-
teries. All measurements were obtained under stable conditions
with a mean arterial pressure of 83 mm Hg (mean 77 ± 15) and a
heart rate between 70 and 87 beats/minute (mean 82 ± 21). Dilti-
azem (0.5e1.0 mg/kg) was infused intraoperatively and during the
ﬁrst 24 h after operation and was thereafter prescribed orally
(100e200 mg/day) for at least 3 months. Standardized dual anti-
platelet therapy was started when chest tube drainage was<20 mL/
h [19]. Statins were given 24 h after surgery and continued in all
patients [20]. Other drugs were given when appropriate.
2.2. Nuclear imaging
Patients were evaluated by two-day stress/rest 99mTc-sestamibi
myocardial perfusion SPECT preoperatively and 36 months after
CABG performed 5 days after therapy withdrawal. Pharmacologic
(dipyridamole) stress testing was preferred to avoid any potential
misleading interference due to different ability to achieve adequate
work level with physical exercise.
Dipyridamole stress testing was performed infusing 0.56 mg/kg
intravenously over 4 min 99mTc-sestamibi, 555 MBq, was injected
intravenously as a bolus 1e2 min before completion of pharma-
cologic stimulation. Dynamic planar images were acquired for 60 s
(4 frames/s) in the anterior view to measure the ﬁrst transit counts
in the pulmonary artery. SPECT was performed 60 min later. No
attenuation or scatter correction was applied. Rest imaging was
performed on a separate day following the same acquisition pro-
tocol. For the assessment of myocardial perfusion 17 segments
were automatically scored and scintigraphic variables incorpo-
rating the extent and severity of regional wall perfusion defects
were calculated. Each segment was scored in a 5-point scale
(0 ¼ normal, 5 ¼ absence of uptake). The Summed rest score (SRS)
and the summed stress score (SSS) were obtained at rest and during
maximal hyperaemia. The summed difference score (SDS), which
Table 2
Distribution of distal anastomoses.
Number 371
LAD Diagonal Circumﬂex RCA
LIMA 148
RA 25 123
SVG 7 23 45
LAD ¼ Left anterior descending. LIMA ¼ Left internal mammary artery. RA ¼ Radial
Artery. RCA ¼ Right coronary artery. SVG ¼ Saphenous vein graft.
Table 3
Intraoperative transient time ﬂow results.
LIMA main stem LIMA distal RA
Free ﬂow (mL/min)
After papaverine 147 ± 36 59 ± 26 72 ± 21
After anastomosis
Maximum ﬂow 121 ± 27 59 ± 18 64 ± 14
Mean ﬂow 62 ± 18 32 ± 14 31 ± 12
Minimum ﬂow 5.2 ± 1.5 2.2 ± 0.7 3.0 ± 0.8
Pulsatility index 1.90 ± 0.8 1.86 ± 0.7
LIMA ¼ left internal mammary artery; RA ¼ radial artery.
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reversibility, was the difference between SSS and SRS. SDS was
scored in a 4-point scale (<2 no ischaemia, 2e4 mild ischaemia,
5e8 moderate ischaemia, >8severe ischaemia). Two experienced
readers evaluated CT images by consensus reading.
2.3. 64-Slice multidetector computed tomography
A CT was scheduled for all patients 36 months after surgery to
evaluate graft patency. The protocol followed for CT scans has been
described previously [21]. Grafts were classiﬁed using a 3-grade
scale: (1) occluded, (2) stenosis  50%, and (3) stenosis < 50% or
no stenosis. Graft occlusion was deﬁned as absence of contrast
material along the course of the graft, from the 1st anastomosis to
the distal native artery [22]. Two experienced readers evaluated CT
images by consensus reading.
2.4. Deﬁnitions and end points
To avoid the bias due to the different duration of follow-up, the
last time point for postoperative evaluation was ﬁxed at 36 post-
operative months in all patients.
End points of the study were the rate of positive scintigrams
induced by dipyridamole and the occurrence of conduits occlusion.
The adverse events rates (deaths, stroke, myocardial infarction,
renal failure, re-exploration for bleeding, sepsis, sternal dehiscence
or wound infections) were indicative of clinical outcome.
Preoperative risk was stratiﬁed by the European system for
cardiac operative risk evaluation (EuroSCORE). Renal dysfunction
was deﬁned as increased serum creatinine value of 2.5 mg/dL or
greater. Acutemyocardial infarctionwas diagnosed according to the
Joint European Society of Cardiology/ACCF/AHA/World Heart
Federation guidelines [23]. The LOS was diagnosed as previously
described [24]. Need for 5 kge1 min1 dopamine or dobutamine
was considered insigniﬁcant. High dose inotropic support, deﬁned
as 7 mg kge1 min1 of dopamine or any dose of adrenaline was
added, was indicative of the postoperative outcome.
2.5. Statistical analysis
Continuous variables were expressed as means ± standard de-
viation and categorical data were expressed as percentages. The
Anderson-Darling test was used to assess the normal distribution.
The paired-sample t test evaluated the differences in continuous
variables between groups for normally distributed values. The
ManneWhitney U test was used for variables not normally
distributed and categorical variables were analysedwith the c2 test
or Fisher's exact test when appropriate. Analysis of factors with
impact on the end points was performed calculating hazard ratio
(HR) with 95% conﬁdential intervals (CI) to assess the impact of
each on the results. All variables with p values less than 0.05 were
considered signiﬁcant and were analysed in a multivariate logistic
regression model. Statistical analysis was performed with SPSS,
version 15.0 for Windows (SPSS Inc, Chicago, IL).
3. Results
3.1. Clinical outcome
A total of 371 distal anastomosis was implanted (296 as com-
posite grafts). Table 2. The average number of distal anastomoses
per patient was 2.5 ± 0.8. The index of completeness (number of
grafts effectively performed on number of grafts intended at
angiography) was 0.94.All patients showed well performing conduits (either Y or veins
grafts) at intraoperative ﬂowmetric measurement. Table 3. Overall
early postoperative outcome was fair and adverse events occurred
at very low rate. Table 4.
Two patients died in the early postoperative period for low-
output syndrome. Five patient showed evidences of perioperative
myocardial infarction. Successful implantation of intraaortic
balloon assistance was performed in 3 patients. Troponin I leakage
in the upper limit of normal occurred in 71 patients (47.9%). High
doses of inotropic drugs were necessary in 21 patients (14.1%). Two
patients were re-explored for postoperative bleeding. No patient
had perioperative strokes, mediastinitis, wound infections, sternal
dehiscence or required dialysis for postoperative new renal insuf-
ﬁciency. Length of hospital stay averaged 7.1 ± 2.5 days. Signiﬁcant
reduction of LVEF at follow up occurred in 13 patients (8.6%) as
compared to preoperative values. LVEF was improved or preserved
in all other patients. Two patients died suddenly 11 and 22 months
after surgery. Two more patients died for myocardial infarction and
congestive heart failure 13 and 18 months after surgery.3.2. Nuclear scintigraphy evaluation
All patients completed the dipyridamole stress test without
major side-effects. Results from nuclear scintigraphy preopera-
tively and 36 months after surgery are depicted in Table 5.
As expected, the number of patients showing signiﬁcant SRS
values was basically similar in either preoperative or postoperative
evaluation meaning a relative low postoperative recovery of the
extent and severity of perfusion defects evidenced at rest. By
contrast, the postoperative improvement of SDS with respect to
preoperative values conﬁrmed the signiﬁcant recovery of inducible
ischaemia in a large proportion of patients. Fig. 1. Notably, 4 pa-
tients of these with postoperative reversible ischaemia had
diseased diagonal or anterolateral branches that were not grafted at
operation because of the poor quality or small diameter, or both. On
the basis of a univariate model signiﬁcant predictors of SDS 2
(evidence of reversible stress induced ischaemia) included age65
years (HR 2.6; 95% CI, 1.8e6.8; p ¼ 0.01), diabetes (HR 3.1; 95% CI,
2.8e7.2; p ¼ 0.007), preoperative history of peripheral vascular
disease (HR 3.8; 95% CI, 3.1e8.2; p ¼ 0.005), corrected TIMI frame
count greater than 30 (HR 4.9; 95% CI, 2.7e11.8; p¼ 0.003), indexed
left ventricular mass (ILVM) greater than 150 g/m2 (HR 2.8; 95% CI,
Table 4
Early postoperative outcome.
Number of anastomosis/patient 2.5 ± 0.8
Completeness index 0.94
Hospital death 2(1.3%)
Ventilation time (hours) 5.8 ± 3.9
Intensive care unit stay (days) 2.2 ± 1.8
Hospital stay (days) 7.1 ± 2.5
Chest tube draining in 24 h (mL) 320 ± 140
Revision for bleeding 2(1.3%)
PAMI 5(3.3%)
Troponin I > 0.5 ng/mL 71(47.9%)
Mean troponin I peak values (ng/mL) 0.61 ± 0.33
Low output syndrome 5(3.3%)
Transient renal failure 3(2%)
High dose of inotropic drugs 21(14.1%).
Sternal wound infection 0
Stroke 0
Values are mean ± SD or numbers; PAMI: perioperative acute myocardial
infarction.
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were corrected TIMI frame count greater than 30 (HR 4.1; 95% CI,
2.1e10.8; p ¼ 0.005) ILVM greater than 150 g/m2 (HR 3.1; 95% CI,
1.5e9.3; p ¼ 0.01).
3.3. Sixty-four-slice multidetector computed tomography
The multidetector CT was completed in 131 patients. Mean
heart rate during data acquisition was 59.8 ± 6 beats/minute. A
total of 262 composite conduits were available for the analysis.
Problems for artefacts from metal clips alongside Y branches
were registered in 4 patients. Excellent graft visualization
including anastomoses was achieved in all the other scanned
grafts. The overall patency rate in the composite system was
95.2% (121/127). Fig. 2. The main stems were patent in all pa-
tients. Severe stenosis or occlusion was evidenced in the distal
LIMA of 4 patients while they occurred in the secondary Y limb of
5 patients. These patients had preserved LV function and were
0e2 Canadian class. They were treated by medical therapy and
were not further evaluated by coronary angiography. One patient,
who showed kinking of the LIMA just proximal to the composite
graft anastomosis site with the RA, was asymptomatic and did
not revealed any evidence of myocardial hypoperfusion at stress/
rest nuclear scintigraphy.
4. Discussion
The extensive use of arterial conduits is the gold standard for
the revascularization of the left coronary system, because of the
excellent long-term patency that is translated into better short-
and long-term outcome. In the quest to perform routine totalTable 5
Nuclear scintigraphy.
Baseline
148 patients
36 months
142 patients
p
SRS 7.3 ± 5.2 5.1 ± 1.8 <0.001
SSS 21.6 ± 7.5 7.1 ± 2.5 <0.001
SDS 14.2 ± 3.5 1.9 ± 0.7 <0.001
SRS  6 69(46.6%) 60(42.2%) 0.5
SDS 5e8 20(13.5%) 6(4.2%) 0.01
SDS  8 128(86.4%) 5(3.5%) <0.001
SSS  13 148(100%) 17(11.9%) <0.001
Values are mean ± SD or numbers of patients (percentages).
SSS ¼ Summed stress score SDS ¼ summed difference score. SRS ¼ Summed rest
score. SSS ¼ Summed stress score.arterial revascularization, composite Y-graft methods gained
increasing popularity in the last years. Used in on-pump or off-
pump surgery, composite arterial grafts overcome the limited
availability of conduits for performing total myocardial revascu-
larization, allow a gain in conduit length and offer the optimal
solution in the challenging situation of high risk of neurologic
injury in patients with diffuse circumferential atherosclerotic
involvement of the ascending aorta that precludes aortic
tangential or cross-clamping. Composite grafts could have an
inherent limitation where the newly constructed coronary ﬂow is
dependent on a single conduit. Although literature is not uni-
form, the composite LIMA/RA Y or T grafts have been demon-
strated able to adapt their dimensions to ﬂow demand and to
supply sufﬁcient ﬂow to distal branches [4,5,10e13]. Further-
more, our previous study demonstrated that the LIMA limb of a
composite Y-graft has intraoperative free and completion ﬂow
comparable to that of the independent LIMA graft both at rest
and during maximal, adenosine-induced hyperaemic response
[5]. In the present study nuclear scintigraphy performed 36
months after surgery conﬁrmed the composite graft as adequate
to provide enough blood supply to heart at rest and during
maximal hyperaemia. As compared to preoperative values the
improved SDS was suggestive of almost complete recovery of the
amount of induced ischaemia that conﬁrms the favourable
behaviour of Y-composite graft. Furthermore, nuclear scintig-
raphy pointed out the strict relationship between the occurrence
of reversible perfusion defects and poor coronary artery run-off/
small target-vessel size (as in higher corrected TIMI frame count)
as well as in patients with higher ILVM probably due to the
inability of composite system to meet the increased blood supply
during maximal recruitment. These results taken together, and
the evidence of the very low rate of graft occlusions, support the
hypothesis that the ﬂow supply in patients who underwent CABG
by LIMA/RA Y-grafts is usually able to provide sufﬁcient blood
ﬂow to the whole left coronary system, but this mainly depends
from the characteristics of the native coronary arteries and the
degree of LV hypertrophy. Consequently, the use of a Y-graft
should be avoided in patients with a history of peripheral
vascular disease, poor coronary artery run-off, and increased
ILVM [25] .
Finally, our results in term of patency rate and myocardial
perfusion support the strictly restrictive use of the RA in composite
Y-graft conﬁguration with LIMA. Following the most substantiated
indications, we used the RA only under the most promising con-
ditions (target vessels with more than 85% stenosis, good run off
and distal size of about 1.5 mm). Probably, this policy allowed to
avoid the occurrence of competitive ﬂow and guaranteed the
optimal perfusion of the whole LV.
This study, although provides a complete angiographic eval-
uation of patients 3 years after surgery, cannot be exhaustive on
patency rate assessment. The follow-up was not long enough and
the variable graft occlusion, which occurred at very low rates,
needs a very large sample for statistical strength. Nonetheless,
our results revealed that graft patency rate of LIMA/RA Y-graft
was similar to that reported in literature for LIMA or RIMA used
as single in situ conduit. It should be also pointed out that the
population of patients enrolled for this study was a relatively low
risk population as patients with low LV function or with signif-
icant comorbidity were excluded. As a consequence, our con-
clusions could not be extended to higher risk population of
patients. Finally it should be mentioned that the accuracy of
99mTc-sestamibi myocardial perfusion SPECT of about 83%
(sensitivity: 85%; speciﬁcity: 72%), by image artefacts caused by
photon attenuation, could have reduced the statistical power of
mioscan ﬁndings.
Fig. 1. Postoperative (36 months) stress/rest 99mTc-sestamibi myocardial perfusion SPECT in a 63-years-old man: evidence of a large perfusion defect during stress that persists at
rest acquisitions.
Fig. 2. Patent composite arterial graft in a 64-year-old man: the left internal mammary artery graft to the left anterior descending coronary artery, together with a radial artery to
the obtuse marginal coronary artery.
V. Mannacio et al. / International Journal of Surgery 12 (2014) 952e9579565. Conclusion
Composite Y-graft was adequate to meet the ﬂow re-
quirements of target coronary artery either at rest or during
maximal hyperaemia and the LIMA main stem was able to adaptits dimension to ﬂow demand. Nevertheless, the use of Y-graft
should be carefully evaluated in patients with LV hypertrophy
and/or poor coronary artery run-off who showed a decreased
graft ﬂow reserve associated to the onset of a reversible induced
ischaemia.
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